Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/136450
Full metadata record
DC FieldValueLanguage
dc.creatorFernando Fernandez-Llimos
dc.creatorDeise Regina Sprada Pontarolli
dc.creatorMargely de Souza Nunes
dc.creatorPaula Rossignoli
dc.creatorPriscila Marys Limberger
dc.date.accessioned2022-09-08T23:58:45Z-
dc.date.available2022-09-08T23:58:45Z-
dc.date.issued2020
dc.identifier.isbn978-65-00-00672-8
dc.identifier.othersigarra:499660
dc.identifier.urihttps://hdl.handle.net/10216/136450-
dc.language.isopor
dc.rightsrestrictedAccess
dc.titleResultados da estratégia da SES/PR perante a incorporação de biossimilar de Etanercepte 50 mg no Componente Especializado da Assistência Farmacêutica
dc.typeLivro
dc.contributor.uportoFaculdade de Farmácia
Appears in Collections:FFUP - Livro

Files in This Item:
File Description SizeFormat 
499660.pdf
  Restricted Access
325.39 kBAdobe PDF    Request a copy from the Author(s)


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.